GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (XTER:EWL) » Definitions » Sale Of Business

Edwards Lifesciences (XTER:EWL) Sale Of Business : €0 Mil (TTM As of Sep. 2024)


View and export this data going back to 1990. Start your Free Trial

What is Edwards Lifesciences Sale Of Business?

Edwards Lifesciences's sale of business for the three months ended in Sep. 2024 was €0 Mil. It means Edwards Lifesciences gained €0 Mil from selling business. Edwards Lifesciences's sale of business for the trailing twelve months (TTM) ended in Sep. 2024 was €0 Mil.

Compared with last quarter (€0 Mil in Jun. 2024 ), Edwards Lifesciences gained the same money from selling business in Sep. 2024 (€0 Mil).

Edwards Lifesciences Sale Of Business Historical Data

The historical data trend for Edwards Lifesciences's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Sale Of Business Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Edwards Lifesciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Edwards Lifesciences Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences Sale Of Business Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (XTER:EWL) » Definitions » Sale Of Business
Comparable Companies
DXCM ZBH STE PODD GMED PEN BIO MASI BRKR GKOS ABT SYK BSX MDT XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 ASX:COH
Traded in Other Exchanges
EW:USA EW:Mexico 1EW:Italy EWL:Germany EWL:Germany E1WL34:Brazil EWLS:Austria
Address
One Edwards Way, Irvine, CA, USA, 92614
Website
https://www.edwards.com
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.